2023 World Conference on Lung Cancer (Posters)-P2.30. Cost Estimation of Radiotherapy for Local Control and Overall Survival Benefit of Lung Cancer in the Australian Population

P2.30. Cost Estimation of Radiotherapy for Local Control and Overall Survival Benefit of Lung Cancer in the Australian Population - PDF(Slides)

Back to course

Pdf Summary

This study aimed to estimate the cost of radiotherapy (RT) for lung cancer in the Australian population and calculate the costs for local control (LC) and overall survival (OS) benefit by stage at diagnosis. The researchers extracted data on all RT activities for lung cancer from July 2017 to June 2020 and consolidated the costs using an activity-based costing method.<br /><br />The results showed that the average cost per treatment course was AUD 5,598 overall, with AUD 5,885 for Stage I-II, AUD 7,363 for Stage III, and AUD 5,225 for Stage IV. The cost for a 1-year local control benefit was AUD 5,974 for Stage I-II and AUD 11,073 for Stage III. The cost for a 1-year overall survival benefit was AUD 8,916 for Stage I-II and AUD 16,547 for Stage III.<br /><br />The study found that the average cost of RT fractions for a one life-year gain was below the cost effectiveness threshold of AUD 50,000. This suggests that radiotherapy is an inexpensive and cost-effective treatment for lung cancer.<br /><br />Overall, this study provides insights into the cost estimation of radiotherapy for lung cancer and highlights the cost effectiveness of this treatment. These findings can be valuable for healthcare providers and policymakers in making decisions regarding the allocation of resources for lung cancer treatment.

Asset Subtitle

Shalini Vinod

Meta Tag

Speaker Shalini Vinod

Topic Global Health, Health Services & Health Economics: Health Economics

Keywords

radiotherapy

lung cancer

cost estimation

Australian population

local control

overall survival

stage at diagnosis

cost effectiveness

healthcare providers

policymakers